Display Settings:

Format

Send to:

Choose Destination
    Exp Toxicol Pathol. 2008 Aug;60(4-5):323-7. Epub 2008 May 29.

    Predictivity of animal studies for human injection site reactions with parenteral drug products.

    Source

    Amgen, Inc., Department of Comparative Biology and Safety Sciences, Thousand Oaks, CA 91320, USA. jengelha@amgen.com

    Abstract

    The value and predictive power of nonclinical studies for potential effects of investigational medicinal products in humans is often debated. The subject of general predictivity of animal toxicity studies has been addressed on several occasions, with one of the most recent efforts being conducted by an ILSI Task Group [Olson H, et al. Concordance of the toxicity of pharmaceuticals in humans and animals. Regul Toxicol Pharmacol 2000; 32: 56-67]. This review provides a summary of the evaluation of cutaneous toxicity, its histopathological assessment, and experience of the biopharmaceutical industry with respect to injection site reactions with parenteral drug products with a pragmatic perspective on the predictivity of standard animal studies with respect to these responses in humans.

    PMID:
    18513931
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk